Dr. Thomas Blackburn

    Dr. Thomas Blackburn is an expert in equity markets and portfolio management, holding a Ph.D. in Financial Economics from Columbia University. With over 18 years of experience in asset management and financial advisory, Thomas has a deep understanding of stock valuation, risk assessment, and capital markets. He is currently the Chief Investment Officer at a renowned investment firm, where he oversees multimillion-dollar portfolios and advises institutional clients on investment strategies. Thomas is known for his pragmatic approach to investment and frequent contributions to financial journals, offering insights into effective asset diversification and risk management.

    Shock on the ASX! One Healthcare Stock is Crashing
    ··

    Shock on the ASX! One Healthcare Stock is Crashing

    Neuren Pharmaceuticals Faces Major Setback Trading began positively for the S&P/ASX 200 Index, but by afternoon, the index’s optimism faded, remaining nearly unchanged at 8,226 points. Among the day’s significant disappointments is Neuren Pharmaceuticals Ltd, which is witnessing a dramatic decline in
    15. January 2025
    1 … 6 7 8 9 10 … 19

    Languages